Overview Consumer Health Products Law and Compliance Issues

Similar documents
Similarity & Difference in OTC Classification and their Borderlines among Asia Pacific

FDA Regulation of Claims on Dietary Supplement and Food Products

Outline of presentation.

TGA: the current regulatory reform agenda

2010/SOM3/LSIF/032 LSIF Initiatives Medical Devices Global Regulatory Harmonization and Anti-Counterfeit Medicines Global Cooperation

An update on the regulatory framework for labelling across the EU Dr David Jukes Department of Food and Nutritional Sciences University of Reading

Guideline for Advertising of e-cigarettes

Getting Your Ingredient to Market: Understanding Your Regulatory Options Venable LLP

Fang-Chi Chang (M.D.,Ph.D.) Center for Drug Evaluation, Taiwan

ON SHELF AVAILABILITY ALIGNMENT PROJECT 2011 ASIA PAC SURVEY RESULTS

CHE8000 Major Research Project A. The Complementary Medicines Reforms and Its Impact to the Complementary Medicine Industry and the Consumer

Guideline on the Regulation of Therapeutic Products in New Zealand

Outline of presentation.

Policy Options for the Regulation of Electronic Cigarettes

Policy Options for the Regulation of Electronic Cigarettes

The Safety and Effectiveness of Dietary Supplements

General Information Booklet on the ASEAN Harmonised Cosmetic Regulatory Scheme

Singapore OTC Switching Regulation

REGULATIONS IN FOOD INGREDIENTS

ASEAN Health Supplements Regulatory Harmonisation Update

Guidelines to Commission Regulation (EU) No 655/2013. laying down common criteria for the justification of claims used

ADVANCED TECHNOLOGY CONFERENCE. The definition of a cosmeceutical. Anthony C. Dweck Research Director, Peter Black Medicare Ltd.

RE: Permits under the Arizona Pharmacy Act should not be required for dietary supplements

Non-Prescription Medicinal Products Containing Codeine: Guidance for Pharmacists on Safe Supply to Patients

7 Day Food Evaluation

MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH

Submission to the Senate Community Affairs Legislation Committee inquiry into the Therapeutic Goods Amendment (2016 Measures No.

Fostering Harmonization of Labelling and Claims in ASEAN Industry Perspective

Improvising Claims. - Dr. R. B. Smarta

How to change the legal classification of a medicine in New Zealand

January 19, Cannabis Legalization and Regulation Secretariat Address locator 0602E Health Canada Ottawa, Ontario K1A 0K9

Scientific Exchange: What Every Compliance Officer Should Consider

Ornsurang Teerawat

JOSEFIEN VENDRIK, QUALITY MANAGER IRENE JONGENELEN, COÖRDINATOR CLINICAL SUPPLIES MANAGEMENT/ SENIOR CLINICAL STUDY MANAGER

OXYCONTIN Diversion & Abuse Drug Enforcement Administration Office of Diversion Control October 2003

Which was the greatest problem with patent medicines in early America that lead to drug legislation?

WHO Framework Convention on Tobacco Control

OVERVIEW OF THE 2017 VFD PROGRAM

Consultation: Discontinuing pre-market evaluation of Herbal Component Names (HCNs)

AUSTRALIAN MADE CAMPAIGN LIMITED

A Family Medicine Cabinet

Mitch Zeller, Director, Center for Tobacco Products, FDA September 19, 2013 Kansas Public Health Association

Coventry Health Care of Georgia, Inc.

Re: National Bioengineered Food Disclosure Standard; Proposed Rule; Request for Comments, 83 Fed. Reg (May 4, 2018), Docket No.

N. BUNYAPRAPHATSARA. ASEAN Harmonization on Traditional Medicine and Health Supplement Registration Requirement

Tobacco control: Best practices. Tara Singh Bam The Union Asia Pacific, Singapore

STATEMENT OF JOSHUA M. SHARFSTEIN, M.D. PRINCIPAL DEPUTY COMMISSIONER U.S. FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES

UNITED STATES REGULATION OF TOBACCO PRODUCTS. Presented by Mitch Zeller Center Director FDA Center for Tobacco Products

How to Regulate E-Cigarettes? Are we asking the right questions?

Claims about health in ads for e-cigarettes. CAP and BCAP s regulatory statement

Policy Options for the Regulation of Electronic Cigarettes

The father of Western medicine, Hippocrates (460 BC BC) is known to have used many plants and herbs for medicinal purposes. Hippocrates' use of

Animal Products Notice

Nutritional Criteria for Labeling Claims

U.S. FDA Perspective on Food Supplements/TM

TOBACCO PRODUCT OR MEDICAL PRODUCT?

The Food for Specific Groups (Information and Compositional Requirements) (England) Regulations 2016

PARKINSON S AND HERBAL SUPPLEMENTS ERICA MARINI, PHARMD UNIVERSITY OF UTAH NEUROLOGY

REGULATORY REQUIREMENTS FOR REGISTRATION OF HEALTH SUPPLEMENTS IN MALAYSIA

European Food Safety Authority

REGULATION AND HTA OF MEDICAL DEVICES IN EU: WHAT CAN WE LEARN?

Update on the revision of the new package leaflet (PL) template. An agency of the European Union

The global regulatory environment for health claims with particular emphasis on Asia

FDLI s Enforcement, Litigation, and Compliance Conference. Center for Tobacco Products Office of Compliance and Enforcement 2017 Update

Guidance Document. 9 May A guidance document issued by the Ministry for Primary Industries

From Wikipedia, the free encyclopedia

Smoking Cessation: A readily modifiable risk factor

Industry and globalisation of herbal medicines

Decoding the Confusing Language of Vitamins. Yuliya Klopouh, M.H., Pharm.D

WHITE PAPER ACCESS TO GOOD QUALITY DIETARY SUPPLEMENTS

Political Economy of the Medical Products Industry

Photos of University Clocktower if they send them to me!!!!!!!

COUNTERFEIT DRUGS IN INDIA

RESULTS AT A GLANCE. FDA Oversight of Tobacco Manufacturing Establishments. HHS OIG Data Brief August 2017 OEI

Improving the regulatory framework for electronic cigarettes (e-cigarettes) and emerging tobacco and nicotine-delivery products

Food Labeling: Policy Rationale IFT Food Policy Impact, 2011

Cancer Council New South Wales: Submission on Public Health (Tobacco) Regulations 2016

Mark M. Yacura. Partner

GUIDELINES FOR USE OF NUTRITION AND HEALTH CLAIMS

Session 2: Direct-to-Consumer Neurotechnology: Dietary Supplements Dietary Ingredients

E-Siong Tee, PhD Scientific Director, ILSI SEA Region

POSSIBLE REVISION OF THE TOBACCO PRODUCTS DIRECTIVE 2001/37/EC PUBLIC CONSULTATION DOCUMENT

Food and Drug Law. Fall Syllabus. Professor Jesson. Hamline University School of Law

Overview of Regulatory Science of Food Contact Substances

December 4, 2017 VIA ELECTRONIC SUBMISSION

The opinions expressed are the speaker s and not his company s.

10 th Seminar on. Nutrition Labeling, Claims and Communication Strategies. Health Claims in Japan. What scientific evidence are we looking for?

FDA s Action Agenda to Reduce Tobacco Related-Cancer Incidence and Mortality

The science behind labeling issues and health claims a European perspective

OFFICIAL STATE BULLETIN

4/26/2013. Libia Lugo Drug Specialist San Juan District Office Investigations Branch

July 3, Re: Proposed Rule: National Bioengineered Food Disclosure Standard. 83 FR (May 4, 2018). Docket No. AMS-TM

COMPETENT AUTHORITY (UK) MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES

Crossing the Line. When does innovative therapy become research?

Regulatory Systems of Health Claims in Japan. June, 2011 Consumer Affairs Agency Food Labelling Division

Taylor C. Wallace, PhD, CFS, FACN, March 22, 2018

Draft Guidelines on the Sale and Supply of Non- Prescription Medicinal Products from a Retail Pharmacy Business

2.1 Naming of foods that are not covered by the scope of existing milk product standards

Australian Jurisdictional Update September 2018

Transcription:

Overview Consumer Health Products Law and Compliance Issues The First Asia Pacific Pharmaceutical Compliance Congress September 2011 CHONG JIN NG Assistant General Counsel Asia Shared Legal Services

Consumer Health Products Agenda Overview of Applicable Law and Codes Current issues / Compliance Challenges Categories Covered Over the Counter Medications ( OTCs ) Cosmetics Health/Dietary Supplements/Nutritionals Medical Devices 2

Framework for OTCs Increased incidence of self-medication Better public health through easy access (e.g. smoking cessation) Savings in healthcare costs (resources used more efficiently) 3

OTCs: Regulatory Principles Key Control Mechanisms (a) Proper labelling (to provide consumer with relevant information) (API, Indications, Safety) (b) Advertising Control (via self or co-regulatory systems) (Truthful claims, Not misleading) (c) Restrictions on retail outlets 4

OTCs Classification as a means of control OTCs make medication more readily available without physician s intervention OTCs can be further classified generally into: (i) (ii) Pharmacy only General sales list Rx products can also be reclassified (at manufacturer s initiation) into OTC status 5

OTCs (cont d) Subject to same general regulatory regime as drugs (marketing approval) (e.g. Drugs Act, Pharmaceutical Affairs Act) Due to safer medical profile, manufacturer can typically request for waiver of clinical data submission, subject to meeting certain criteria. Regulatory approval also utilises concept of reference agencies (Australia TGA, US FDA, UK MHRA) and standard reference texts (on the use of active ingredient) 6

OTCs (cont d) Industry Associations World Self-Medication Industry (WSMI) U.S.A CHPA (Consumer Healthcare Products Association) CHPA has its own voluntary code and guidelines Asia Pacific Australia, China, Taiwan, Indonesia, Japan, Korea, Malaysia and New Zealand 7

OTCs: Ongoing Issues Methamphetamine ( Meth ) and Pseudoephedrine ( PDE ) Abuse PDE widely used OTC decongestant which can be used to manufacture Meth Meth illegal and highly addictive drug U.S legislation: Combat Meth Epidemic Act (2006) 8

Cosmetics Definition A Cosmetic Product is any substance of preparation that is intended to be placed in contact with the various external parts of the human body or with the teeth and the mucous membranes of the oral cavity with a view exclusively or mainly cleaning them, perfuming them, changing their appearance, correcting body odours, protecting them or keeping them in good condition. - Includes lotions, gels and oral care products 9

Cosmetics Regulatory Regime Often times, manufacturers market a cosmetic product (with drug/health claims) without adhering to drug regulatory laws. Cosmeceutical a product which is both a drug and a cosmetic. No legal meaning but suggests that product may have some therapeutic effect. 10

Cosmetics Regulatory Regime (cont d) USA FDA is the regulatory authority Applicable Law (i) Federal Food Drug & Cosmetic Act (ii) Fair Packaging & Labelling Act ASEAN Cosmetic Directive To harmonise the regulation of cosmetics in the region Member states to ensure that only cosmetics which conform to Directive can be put onto the market. Manufacturer/Supplier has obligation to notify relevant regulator of place of manufacture or of initial importation before general sale. 11

ASEAN Directive Standardised labelling requirements Information required include the following: Functions Instructions for use Full ingredients for listing Manufacturing / Expiry date Special precautions if any 12

Hot Issues Poor compliance with advertising standards in certain segments: (i) (ii) efficiency claims for skin creams (cumulative claims) ultra-scientific claims (e.g. cell regeneration) (iii) dermatologist tested claims (what does this really mean) 13

Health/Dietary Supplements/Regulatory Regime Definition Product that is taken by mouth and contains dietary ingredient intended to supplement diet. Dietary Ingredients ( DI ) include vitamins, minerals, herbs, amino acids, any substance to supplement diet by increasing total dietary intakes (e.g. enzymes) AP region: Regulatory regime governed by combination of: Food Laws Regulations from local FDA Consumer Protection Laws 14

Singapore: Health Supplements Guidelines Guidelines define Health Supplements to include: (i) (ii) Traditional Medicines Health Foods (with vague and general medicinal claims) Working Definition A product used to supplement a diet, with benefits beyond those of normal nutrients, and/or to support/maintain healthy functions of the body. No pre-marketing approval system in place. 15

HS: Claims Guidelines Claims must be consistent with definition of HS Cannot be advertised for medicinal purpose (treatment or prevention, implied or otherwise of any disease or disorder) Must not be misleading or which cannot be adequately substantial Labelling Guidance 16

HS: Nutritional Health Claims (General) Permitted provided they contain well-documented ingredients which function is supported in standard reference texts and is adequately substantiated. Include (a) general health maintenance (b) vitamin and/or mineral supplementation (c) supports healthy function of human body 17

Medical Devices Definition a product/device that is represented for use by humans or is part of a class of substances, preparations or devices intended for use by humans solely or principally for health-related purposes Includes simple bandages, surgery equipment, medical diagnostic equipment 18

Regulatory Regime Not as complicated as pharmaceutical regulation. Where regime is in place, marketing authorisations are required. Classification system is risk-based. Various industry associations: e.g. AdvaMed (Advance Medical Technology Association) but no single global association to cover entire industry. 19

Medical Devices: Compliance Issues Ethical collaboration with HCPs to advance medical technology. HCP: innovators/having equity ownership. FCPA focus 20

Q&A Thank You!